Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04607746 · ClinicalTrials.gov registry record · NA

Pivotal Study of the CapsoCam Colon (CV-3) in Detecting Colonic Polyps, Using Colonoscopy as the Reference

A NA study, sponsored by Capso Vision.

Completed
Registry status
NA
Development phase
1,337
Enrollment target

NCT04607746 is a NA study that has completed, run by Capso Vision. The registered enrollment target is 1,337 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04607746, a NA study, has completed, sponsored by Capso Vision.

COMPLETED
Registry status
NA
Development phase
1,337 participants
Enrollment target

Study Summary

This study will evaluate the safety and effectiveness of the CapsoCam Colon (CV-3) endoscope system for the detection of colonic polyps.

Interventions

  • DEVICE Capsule Endoscope

Trial Details

FieldValue
Enrollment Target 1,337 participants
Start Date 2021-01-06
Est. Completion 2025-02-14
Phase NA

Sponsor

Capso Vision

6 total trials

What the Registry Record Tells You About NCT04607746

The ClinicalTrials.gov registry entry for NCT04607746 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,337 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Capso Vision, which has 6 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Capsule Endoscope is the first listed.

NCT04607746 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04607746 about?

NCT04607746 is a clinical study titled "Pivotal Study of the CapsoCam Colon (CV-3) in Detecting Colonic Polyps, Using Colonoscopy as the Reference". This study will evaluate the safety and effectiveness of the CapsoCam Colon (CV-3) endoscope system for the detection of colonic polyps.

What is the current status of trial NCT04607746?

This trial is currently completed. It is a NA study. The enrollment target is 1,337 participants. The study started on 2021-01-06. Estimated completion is 2025-02-14.

What interventions are being tested in trial NCT04607746?

The interventions under investigation include: Capsule Endoscope (DEVICE).

Who is sponsoring clinical trial NCT04607746?

This trial is sponsored by Capso Vision, which has 6 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.